Refractory Sjogrens syndrome: Is parotidectomy justified?
| Autor: | Singh AG; Department of Oral and Maxillofacial Surgery, KLE VKIDS, Belagavi, Karnataka, India., Umarani MV; Department of Oral and Maxillofacial Surgery, KLE VKIDS, Belagavi, Karnataka, India., Muttagi S; Department of Oral and Maxillofacial Surgery, KLE VKIDS, Belagavi, Karnataka, India. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | National journal of maxillofacial surgery [Natl J Maxillofac Surg] 2019 Jul-Dec; Vol. 10 (2), pp. 257-259. Date of Electronic Publication: 2019 Nov 12. |
| DOI: | 10.4103/njms.NJMS_50_15 |
| Abstrakt: | Primary and secondary Sjogrens syndrome (SS) is the classification used, according to the American-European Consensus Group Criteria. Salivary and lacrimal gland dysfunctions are the usual hallmark of the disease, but the involvement of other exocrine glands and extraglandular manifestations of the disease do occur. In rare cases, few patients are refractory to the conventional therapy and due to the sudden increase in size of a mass and the esthetic and psychological concerns of a "cancerous growth," the surgical treatment modalities have to be modified. There is a significant lack of contemporary literature on the indications for surgery in refractory SS, and the option should be given in patients with esthetic concerns, risk of malignancy, and to improve the overall quality of life. Competing Interests: There are no conflicts of interest. (Copyright: © 2019 National Journal of Maxillofacial Surgery.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|